Aft Pharms Ltd Drug Patent Portfolio

Aft Pharms Ltd owns 1 orange book drug protected by 3 US patents Given below is the list of Aft Pharms Ltd's drug patents along with their expiration dates.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US11197830 Pharmaceutical composition containing acetaminophen and ibuprofen 27 Feb, 2039
Active
US11534407 Pharmaceutical compostion containing acetominophen and ibuprofen 27 Feb, 2039
Active
US10532036 Combination composition 22 Sep, 2025
Active


Given below is the list of recent legal activities going on the following drug patents of Aft Pharms Ltd.

Activity Date Patent Number
Patent litigations
Payment of Maintenance Fee, 4th Yr, Small Entity 28 Jun, 2023 US10532036
Post Issue Communication - Certificate of Correction 06 Jun, 2023 US11534407
Patent Issue Date Used in PTA Calculation 27 Dec, 2022 US11534407
Recordation of Patent Grant Mailed 27 Dec, 2022 US11534407
Email Notification 08 Dec, 2022 US11534407
Issue Notification Mailed 07 Dec, 2022 US11534407
Dispatch to FDC 23 Nov, 2022 US11534407
Application Is Considered Ready for Issue 23 Nov, 2022 US11534407
Issue Fee Payment Received 18 Nov, 2022 US11534407
Issue Fee Payment Verified 18 Nov, 2022 US11534407
Response to Reasons for Allowance 18 Nov, 2022 US11534407
Mailing Corrected Notice of Allowability 09 Nov, 2022 US11534407
Email Notification 09 Nov, 2022 US11534407
Corrected Notice of Allowability 03 Nov, 2022 US11534407
Information Disclosure Statement considered 03 Nov, 2022 US11534407


Aft Pharms Ltd's Family Patents

Aft Pharms Ltd drugs have patent protection in a total of 31 countries. It's US patent count contributes only to 16.7% of its total global patent coverage. 2 countries have all of their patents expired or invalidated which has opened up potential generic launch opportunities in these countries. Click below to unlock the full patent family tree.

Family Patents



Aft Pharms Ltd Drug List

Given below is the complete list of Aft Pharms Ltd's drugs and the patents protecting them.


1. Combogesic

Combogesic is protected by 3 patents, out of which none have expired yet. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US11197830 Pharmaceutical composition containing acetaminophen and ibuprofen 27 Feb, 2039
(14 years from now)
Active
US11534407 Pharmaceutical compostion containing acetominophen and ibuprofen 27 Feb, 2039
(14 years from now)
Active
US10532036 Combination composition 22 Sep, 2025
(11 months from now)
Active

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Combogesic's drug page


Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List